This week marks the exciting launch of the PIPELINE project, a groundbreaking initiative dedicated to improving the health of pregnant people and infants across Europe. Recognising the critical need to…
Penta is thrilled to announce the launch of READI (Research in Europe and Diversity Inclusion), a new project funded by the Innovative Health Initiative, aiming to promote a comprehensively inclusive…
The final training phase through an innovative e-learning platform involving more than 1,000 healthcare workers from Spain, Italy and Greece has just been launched after a successful pilot phase in…
A significant milestone has been reached in the fight against paediatric HIV with the enrolment of the first participants in the UNIVERSAL1 trial. This achievement is a testament to the…
It was in my early days as a Penta Young Reporter that I was given the opportunity to interview the highly regarded Paediatric HIV consultant, Dr. Noella Pereira from the…
As the monkeypox virus continues to pose a threat to global health, EU-funded researchers are working together with international partners to manage the disease and protect the most vulnerable.
Antimicrobial resistance (AMR), as defined by the WHO, occurs when bacteria, viruses, fungi, and parasites no longer respond to medications. This is a growing global health crisis because AMR makes infections…
ReCAP is a series of interviews with the members of the RBDCOV Community Advisory Panel that will explore the world of community engagement in EU projects and the importance of…
The Laboratory of Medical Microbiology at the University of Antwerp, Belgium, plays a crucial role in the NeoIPC project, acting as the central microbiology laboratory for its various studies.
The ORCHESTRA project, “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic”, has officially concluded. This European research initiative brought together scientists from 37 different partner institutions from…
In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.
Every year, on September 13th, we observe World Sepsis Day, an important date in the calendar to raise awareness about sepsis – a life-threatening condition that occurs when the body’s response…
Our early career researchers gathered at the PIM 2024 which provided a great opportunity for these young professionals to discuss collaboration opportunities, career development, exchange ideas and update each other on their career trajectories and ongoing projects.
Our 3-day PentaTr@ining Namibia 2024 residential course came to a close on July 4th 2024. The course was organised in partnership with several key stakeholders, including the Namibia HIV Clinicians…
Laurus Labs has submitted an application to the US Food and Drug Administration (FDA) for the tentative approval of paediatric Darunavir/ritonavir (pDRV/r (120/20 mg)). UNIVERSAL is the first product development…
Analytical treatment interruption (ATI) is a crucial component of HIV cure research, but discussions have largely focused on adult populations. A recent expert opinion from the EPIICAL consortium,
We are thrilled to announce the release of the Action Plan “Accelerating bnAbs for Peri- and Post-Natal HIV Prophylaxis”. Developed by a Task Force of leading experts and stakeholders,